カテゴリ： LP Information, 世界, 医療/バイオ

冠動脈薬剤ステントシステムの世界市場2022-2028：高分子ポリマー担体、高分子ポリマー担体なし

■ 英語タイトル：Global Coronary Drug Stent System Market Growth 2022-2028
	■ 発行会社/調査会社：LP Information ■ 商品コード：LP22DC4508 ■ 発行日：2022年12月 ■ 調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ■ 産業分野：医療機器 ■ ページ数：101 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[冠動脈薬剤ステントシステムの世界市場2022-2028：高分子ポリマー担体、高分子ポリマー担体なし]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

冠動脈薬剤ステントシステムのグローバル市場規模は、2021年のxxx百万ドルから2028年までにxxx百万ドルに増加すると推定されており、2022年～2028年の年平均成長率（CAGR）はxx%を示しています。COVID-19とロシア・ウクライナ戦争の不確実性を念頭に置いて、さまざまな最終用途部門に対するパンデミックの直接的および間接的な影響を継続的に追跡・分析しています。これらのインサイトは、主要な市場要因としてレポートに含まれています。
冠動脈薬剤ステントシステムのアジア太平洋市場は、2022年にxxx百万ドルの市場規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。冠動脈薬剤ステントシステムの米国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。冠動脈薬剤ステントシステムのヨーロッパ市場は、2022年にxxx百万ドルの規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。冠動脈薬剤ステントシステムの中国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。

世界の主要な冠動脈薬剤ステントシステム関連企業としては、Medtronic、 Boston Scientific、 Biosensors、 Terumo、 MicroPort、 Lepu Medical、 B.Braun、 Atrium Medical、 SINOMED、 LBC、 Essen Technology、 Yinyi Biotech CO.,LTD.などをカバーしています。売上の面では世界最大の2社が2021年にほぼxx%の市場シェアを占めています。

*** レポート範囲 ***

この最新のレポートはすべての重要な側面をカバーしながら冠動脈薬剤ステントシステムのグローバル市場に関する深いインサイトを提供します。これは、市場のマクロな概要から、市場規模、競争環境、開発動向、ニッチ市場、主要な市場ドライバーと課題、バリューチェーン分析などのミクロの詳細にまで及びます。当レポートは読者がパンデミックおよびロシア・ウクライナ戦争中に世界中で冠動脈薬剤ステントシステム市場シナリオがどのように変化したかを理解できるように定量的データと定性的データの両方を使用して、冠動脈薬剤ステントシステムのグローバル市場の全体像を提供することを目的としています。

分析の対象となる基準年は2021年で、市場の予測は2022年～2028年までのものです。

*** 市場セグメンテーション ***

この調査では冠動脈薬剤ステントシステム市場を細分化し、種類別 (高分子ポリマー担体、高分子ポリマー担体なし)、用途別 (病院、診療所)、および地域別 (アジア太平洋、アメリカ州、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：高分子ポリマー担体、高分子ポリマー担体なし

・用途別区分：病院、診療所

・地域別区分
アメリカ州（アメリカ、カナダ、メキシコ、ブラジル）
APAC/アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

*** 各章の紹介 ***
第1章：冠動脈薬剤ステントシステムの範囲、調査方法など
第2章：エグゼクティブサマリー、世界の冠動脈薬剤ステントシステム市場規模 (販売量、売上) およびCAGR、地域別・種類別・用途別、2017年～2022年までの推移データ、および2028年までの市場予測
第3章：企業別冠動脈薬剤ステントシステムの販売量、売上、平均価格、グローバル市場シェア、および業界ランキング
第4章：地域別および国別の冠動脈薬剤ステントシステムの販売量と売上（米国、カナダ、ヨーロッパ、中国、日本、韓国、東南アジア、インド、ラテンアメリカ、中東・アフリカなど）
第5/6/7/8章：アメリカ州、アジア太平洋、ヨーロッパ、中東・アフリカの国別、種類別の販売セグメント
第9章：市場動向、市場予測、機会、将来の市場に影響を与える経済動向の分析
第10章：製造コスト構造分析
第11章：販売チャンネル、販売業者および顧客
第12章：地域別、国別、種類別、用途別の世界の冠動脈薬剤ステントシステム市場規模予測
第13章：主要企業の包括的な企業プロファイル
第14章：調査の結果

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：冠動脈薬剤ステントシステムの年間販売量2017-2028、地域別現状・将来分析
・冠動脈薬剤ステントシステムの種類別セグメント：高分子ポリマー担体、高分子ポリマー担体なし
・冠動脈薬剤ステントシステムの種類別販売量：2017-2022年の販売量、売上、市場シェア、販売価格
・冠動脈薬剤ステントシステムの用途別セグメント：病院、診療所
・冠動脈薬剤ステントシステムの用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界の冠動脈薬剤ステントシステム市場
・企業別のグローバル冠動脈薬剤ステントシステム市場データ：2020-2022年の年間販売量、市場シェア
・企業別の冠動脈薬剤ステントシステムの年間売上：2020-2022年の売上、市場シェア
・企業別の冠動脈薬剤ステントシステム販売価格
・主要企業の冠動脈薬剤ステントシステム生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

冠動脈薬剤ステントシステムの地域別レビュー
・地域別の冠動脈薬剤ステントシステム市場規模2017-2022：年間販売量、売上
・主要国別の冠動脈薬剤ステントシステム市場規模2017-2022：年間販売量、売上
・アメリカ州の冠動脈薬剤ステントシステム販売の成長
・アジア太平洋の冠動脈薬剤ステントシステム販売の成長
・ヨーロッパの冠動脈薬剤ステントシステム販売の成長
・中東・アフリカの冠動脈薬剤ステントシステム販売の成長

アメリカ州市場
・アメリカ州の国別の冠動脈薬剤ステントシステム販売量、売上（2017-2022）
・アメリカ州の冠動脈薬剤ステントシステムの種類別販売量
・アメリカ州の冠動脈薬剤ステントシステムの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋（APAC）市場
・アジア太平洋の国別の冠動脈薬剤ステントシステム販売量、売上（2017-2022）
・アジア太平洋の冠動脈薬剤ステントシステムの種類別販売量
・アジア太平洋の冠動脈薬剤ステントシステムの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の冠動脈薬剤ステントシステム販売量、売上（2017-2022）
・ヨーロッパの冠動脈薬剤ステントシステムの種類別販売量
・ヨーロッパの冠動脈薬剤ステントシステムの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の冠動脈薬剤ステントシステム販売量、売上（2017-2022）
・中東・アフリカの冠動脈薬剤ステントシステムの種類別販売量
・中東・アフリカの冠動脈薬剤ステントシステムの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・冠動脈薬剤ステントシステムの製造コスト構造分析
・冠動脈薬剤ステントシステムの製造プロセス分析
・冠動脈薬剤ステントシステムの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・冠動脈薬剤ステントシステムの主要なグローバル販売業者
・冠動脈薬剤ステントシステムの主要なグローバル顧客

地域別の冠動脈薬剤ステントシステム市場予測レビュー
・地域別の冠動脈薬剤ステントシステム市場規模予測（2023-2028）
・アメリカ州の国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・冠動脈薬剤ステントシステムの種類別市場規模予測
・冠動脈薬剤ステントシステムの用途別市場規模予測

主要企業分析
Medtronic、 Boston Scientific、 Biosensors、 Terumo、 MicroPort、 Lepu Medical、 B.Braun、 Atrium Medical、 SINOMED、 LBC、 Essen Technology、 Yinyi Biotech CO.,LTD.
・企業情報
・冠動脈薬剤ステントシステム製品
・冠動脈薬剤ステントシステム販売量、売上、価格、粗利益（2020-2022）
・主要ビジネス概要
・最新動向

調査の結果

It is used to treat narrowed or blocked blood vessels in the heart by reflowing blood through the blood vessels with an inflated balloon. A coronary stent is then placed into the vessel to ensure it remains open. Two types of stents are available, one that is coated with a drug to reduce the risk of future blockages (drug-eluting stents) and one that is uncoated (bare-metal stents).
The global market for Coronary Drug Stent System is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Coronary Drug Stent System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Coronary Drug Stent System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Coronary Drug Stent System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Coronary Drug Stent System market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Coronary Drug Stent System players cover Medtronic, Boston Scientific, Biosensors, Terumo and MicroPort, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

[Report Coverage]
This latest report provides a deep insight into the global Coronary Drug Stent System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Coronary Drug Stent System market, with both quantitative and qualitative data, to help readers understand how the Coronary Drug Stent System market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

[Market Segmentation]
The study segments the Coronary Drug Stent System market and forecasts the market size by Type (High Molecular Polymer Carrier and No High Molecular Polymer Carrier,), by Application (Hospitals and Clinics.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
High Molecular Polymer Carrier
No High Molecular Polymer Carrier
Segmentation by application
Hospitals
Clinics
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Medtronic
Boston Scientific
Biosensors
Terumo
MicroPort
Lepu Medical
B.Braun
Atrium Medical
SINOMED
LBC
Essen Technology
Yinyi Biotech CO.,LTD.

[Chapter Introduction]
Chapter 1: Scope of Coronary Drug Stent System, Research Methodology, etc.
Chapter 2: Executive Summary, global Coronary Drug Stent System market size (sales and revenue) and CAGR, Coronary Drug Stent System market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Coronary Drug Stent System sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Coronary Drug Stent System sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Coronary Drug Stent System market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical and SINOMED, etc.
Chapter 14: Research Findings and Conclusion

*** レポート目次（コンテンツ）***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coronary Drug Stent System Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Coronary Drug Stent System by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Coronary Drug Stent System by Country/Region, 2017, 2022 & 2028
2.2 Coronary Drug Stent System Segment by Type
2.2.1 High Molecular Polymer Carrier
2.2.2 No High Molecular Polymer Carrier
2.3 Coronary Drug Stent System Sales by Type
2.3.1 Global Coronary Drug Stent System Sales Market Share by Type (2017-2022)
2.3.2 Global Coronary Drug Stent System Revenue and Market Share by Type (2017-2022)
2.3.3 Global Coronary Drug Stent System Sale Price by Type (2017-2022)
2.4 Coronary Drug Stent System Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Coronary Drug Stent System Sales by Application
2.5.1 Global Coronary Drug Stent System Sale Market Share by Application (2017-2022)
2.5.2 Global Coronary Drug Stent System Revenue and Market Share by Application (2017-2022)
2.5.3 Global Coronary Drug Stent System Sale Price by Application (2017-2022)
3 Global Coronary Drug Stent System by Company
3.1 Global Coronary Drug Stent System Breakdown Data by Company
3.1.1 Global Coronary Drug Stent System Annual Sales by Company (2020-2022)
3.1.2 Global Coronary Drug Stent System Sales Market Share by Company (2020-2022)
3.2 Global Coronary Drug Stent System Annual Revenue by Company (2020-2022)
3.2.1 Global Coronary Drug Stent System Revenue by Company (2020-2022)
3.2.2 Global Coronary Drug Stent System Revenue Market Share by Company (2020-2022)
3.3 Global Coronary Drug Stent System Sale Price by Company
3.4 Key Manufacturers Coronary Drug Stent System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coronary Drug Stent System Product Location Distribution
3.4.2 Players Coronary Drug Stent System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Coronary Drug Stent System by Geographic Region
4.1 World Historic Coronary Drug Stent System Market Size by Geographic Region (2017-2022)
4.1.1 Global Coronary Drug Stent System Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Coronary Drug Stent System Annual Revenue by Geographic Region
4.2 World Historic Coronary Drug Stent System Market Size by Country/Region (2017-2022)
4.2.1 Global Coronary Drug Stent System Annual Sales by Country/Region (2017-2022)
4.2.2 Global Coronary Drug Stent System Annual Revenue by Country/Region
4.3 Americas Coronary Drug Stent System Sales Growth
4.4 APAC Coronary Drug Stent System Sales Growth
4.5 Europe Coronary Drug Stent System Sales Growth
4.6 Middle East & Africa Coronary Drug Stent System Sales Growth
5 Americas
5.1 Americas Coronary Drug Stent System Sales by Country
5.1.1 Americas Coronary Drug Stent System Sales by Country (2017-2022)
5.1.2 Americas Coronary Drug Stent System Revenue by Country (2017-2022)
5.2 Americas Coronary Drug Stent System Sales by Type
5.3 Americas Coronary Drug Stent System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coronary Drug Stent System Sales by Region
6.1.1 APAC Coronary Drug Stent System Sales by Region (2017-2022)
6.1.2 APAC Coronary Drug Stent System Revenue by Region (2017-2022)
6.2 APAC Coronary Drug Stent System Sales by Type
6.3 APAC Coronary Drug Stent System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Coronary Drug Stent System by Country
7.1.1 Europe Coronary Drug Stent System Sales by Country (2017-2022)
7.1.2 Europe Coronary Drug Stent System Revenue by Country (2017-2022)
7.2 Europe Coronary Drug Stent System Sales by Type
7.3 Europe Coronary Drug Stent System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coronary Drug Stent System by Country
8.1.1 Middle East & Africa Coronary Drug Stent System Sales by Country (2017-2022)
8.1.2 Middle East & Africa Coronary Drug Stent System Revenue by Country (2017-2022)
8.2 Middle East & Africa Coronary Drug Stent System Sales by Type
8.3 Middle East & Africa Coronary Drug Stent System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coronary Drug Stent System
10.3 Manufacturing Process Analysis of Coronary Drug Stent System
10.4 Industry Chain Structure of Coronary Drug Stent System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coronary Drug Stent System Distributors
11.3 Coronary Drug Stent System Customer
12 World Forecast Review for Coronary Drug Stent System by Geographic Region
12.1 Global Coronary Drug Stent System Market Size Forecast by Region
12.1.1 Global Coronary Drug Stent System Forecast by Region (2023-2028)
12.1.2 Global Coronary Drug Stent System Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coronary Drug Stent System Forecast by Type
12.7 Global Coronary Drug Stent System Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Coronary Drug Stent System Product Offered
13.1.3 Medtronic Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Coronary Drug Stent System Product Offered
13.2.3 Boston Scientific Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Biosensors
13.3.1 Biosensors Company Information
13.3.2 Biosensors Coronary Drug Stent System Product Offered
13.3.3 Biosensors Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biosensors Main Business Overview
13.3.5 Biosensors Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Coronary Drug Stent System Product Offered
13.4.3 Terumo Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 MicroPort
13.5.1 MicroPort Company Information
13.5.2 MicroPort Coronary Drug Stent System Product Offered
13.5.3 MicroPort Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MicroPort Main Business Overview
13.5.5 MicroPort Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Coronary Drug Stent System Product Offered
13.6.3 Lepu Medical Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 B.Braun
13.7.1 B.Braun Company Information
13.7.2 B.Braun Coronary Drug Stent System Product Offered
13.7.3 B.Braun Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 B.Braun Main Business Overview
13.7.5 B.Braun Latest Developments
13.8 Atrium Medical
13.8.1 Atrium Medical Company Information
13.8.2 Atrium Medical Coronary Drug Stent System Product Offered
13.8.3 Atrium Medical Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Atrium Medical Main Business Overview
13.8.5 Atrium Medical Latest Developments
13.9 SINOMED
13.9.1 SINOMED Company Information
13.9.2 SINOMED Coronary Drug Stent System Product Offered
13.9.3 SINOMED Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SINOMED Main Business Overview
13.9.5 SINOMED Latest Developments
13.10 LBC
13.10.1 LBC Company Information
13.10.2 LBC Coronary Drug Stent System Product Offered
13.10.3 LBC Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 LBC Main Business Overview
13.10.5 LBC Latest Developments
13.11 Essen Technology
13.11.1 Essen Technology Company Information
13.11.2 Essen Technology Coronary Drug Stent System Product Offered
13.11.3 Essen Technology Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Essen Technology Main Business Overview
13.11.5 Essen Technology Latest Developments
13.12 Yinyi Biotech CO.,LTD.
13.12.1 Yinyi Biotech CO.,LTD. Company Information
13.12.2 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product Offered
13.12.3 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Yinyi Biotech CO.,LTD. Main Business Overview
13.12.5 Yinyi Biotech CO.,LTD. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Coronary Drug Stent System Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Coronary Drug Stent System Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of High Molecular Polymer Carrier
Table 4. Major Players of No High Molecular Polymer Carrier
Table 5. Global Coronary Drug Stent System Sales by Type (2017-2022) & (K Units)
Table 6. Global Coronary Drug Stent System Sales Market Share by Type (2017-2022)
Table 7. Global Coronary Drug Stent System Revenue by Type (2017-2022) & ($ million)
Table 8. Global Coronary Drug Stent System Revenue Market Share by Type (2017-2022)
Table 9. Global Coronary Drug Stent System Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Coronary Drug Stent System Sales by Application (2017-2022) & (K Units)
Table 11. Global Coronary Drug Stent System Sales Market Share by Application (2017-2022)
Table 12. Global Coronary Drug Stent System Revenue by Application (2017-2022)
Table 13. Global Coronary Drug Stent System Revenue Market Share by Application (2017-2022)
Table 14. Global Coronary Drug Stent System Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Coronary Drug Stent System Sales by Company (2020-2022) & (K Units)
Table 16. Global Coronary Drug Stent System Sales Market Share by Company (2020-2022)
Table 17. Global Coronary Drug Stent System Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Coronary Drug Stent System Revenue Market Share by Company (2020-2022)
Table 19. Global Coronary Drug Stent System Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Coronary Drug Stent System Producing Area Distribution and Sales Area
Table 21. Players Coronary Drug Stent System Products Offered
Table 22. Coronary Drug Stent System Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Coronary Drug Stent System Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Coronary Drug Stent System Sales Market Share Geographic Region (2017-2022)
Table 27. Global Coronary Drug Stent System Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Coronary Drug Stent System Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Coronary Drug Stent System Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Coronary Drug Stent System Sales Market Share by Country/Region (2017-2022)
Table 31. Global Coronary Drug Stent System Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Coronary Drug Stent System Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Coronary Drug Stent System Sales by Country (2017-2022) & (K Units)
Table 34. Americas Coronary Drug Stent System Sales Market Share by Country (2017-2022)
Table 35. Americas Coronary Drug Stent System Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Coronary Drug Stent System Revenue Market Share by Country (2017-2022)
Table 37. Americas Coronary Drug Stent System Sales by Type (2017-2022) & (K Units)
Table 38. Americas Coronary Drug Stent System Sales Market Share by Type (2017-2022)
Table 39. Americas Coronary Drug Stent System Sales by Application (2017-2022) & (K Units)
Table 40. Americas Coronary Drug Stent System Sales Market Share by Application (2017-2022)
Table 41. APAC Coronary Drug Stent System Sales by Region (2017-2022) & (K Units)
Table 42. APAC Coronary Drug Stent System Sales Market Share by Region (2017-2022)
Table 43. APAC Coronary Drug Stent System Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Coronary Drug Stent System Revenue Market Share by Region (2017-2022)
Table 45. APAC Coronary Drug Stent System Sales by Type (2017-2022) & (K Units)
Table 46. APAC Coronary Drug Stent System Sales Market Share by Type (2017-2022)
Table 47. APAC Coronary Drug Stent System Sales by Application (2017-2022) & (K Units)
Table 48. APAC Coronary Drug Stent System Sales Market Share by Application (2017-2022)
Table 49. Europe Coronary Drug Stent System Sales by Country (2017-2022) & (K Units)
Table 50. Europe Coronary Drug Stent System Sales Market Share by Country (2017-2022)
Table 51. Europe Coronary Drug Stent System Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Coronary Drug Stent System Revenue Market Share by Country (2017-2022)
Table 53. Europe Coronary Drug Stent System Sales by Type (2017-2022) & (K Units)
Table 54. Europe Coronary Drug Stent System Sales Market Share by Type (2017-2022)
Table 55. Europe Coronary Drug Stent System Sales by Application (2017-2022) & (K Units)
Table 56. Europe Coronary Drug Stent System Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Coronary Drug Stent System Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Coronary Drug Stent System Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Coronary Drug Stent System Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Coronary Drug Stent System Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Coronary Drug Stent System Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Coronary Drug Stent System Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Coronary Drug Stent System Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Coronary Drug Stent System Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Coronary Drug Stent System
Table 66. Key Market Challenges & Risks of Coronary Drug Stent System
Table 67. Key Industry Trends of Coronary Drug Stent System
Table 68. Coronary Drug Stent System Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Coronary Drug Stent System Distributors List
Table 71. Coronary Drug Stent System Customer List
Table 72. Global Coronary Drug Stent System Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Coronary Drug Stent System Sales Market Forecast by Region
Table 74. Global Coronary Drug Stent System Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Coronary Drug Stent System Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Coronary Drug Stent System Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Coronary Drug Stent System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Coronary Drug Stent System Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Coronary Drug Stent System Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Coronary Drug Stent System Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Coronary Drug Stent System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Coronary Drug Stent System Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Coronary Drug Stent System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Coronary Drug Stent System Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Coronary Drug Stent System Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Coronary Drug Stent System Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Coronary Drug Stent System Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Coronary Drug Stent System Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Coronary Drug Stent System Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Coronary Drug Stent System Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Coronary Drug Stent System Revenue Market Share Forecast by Application (2023-2028)
Table 92. Medtronic Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 93. Medtronic Coronary Drug Stent System Product Offered
Table 94. Medtronic Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Medtronic Main Business
Table 96. Medtronic Latest Developments
Table 97. Boston Scientific Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific Coronary Drug Stent System Product Offered
Table 99. Boston Scientific Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Boston Scientific Main Business
Table 101. Boston Scientific Latest Developments
Table 102. Biosensors Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 103. Biosensors Coronary Drug Stent System Product Offered
Table 104. Biosensors Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Biosensors Main Business
Table 106. Biosensors Latest Developments
Table 107. Terumo Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 108. Terumo Coronary Drug Stent System Product Offered
Table 109. Terumo Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Terumo Main Business
Table 111. Terumo Latest Developments
Table 112. MicroPort Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 113. MicroPort Coronary Drug Stent System Product Offered
Table 114. MicroPort Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. MicroPort Main Business
Table 116. MicroPort Latest Developments
Table 117. Lepu Medical Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 118. Lepu Medical Coronary Drug Stent System Product Offered
Table 119. Lepu Medical Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Lepu Medical Main Business
Table 121. Lepu Medical Latest Developments
Table 122. B.Braun Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 123. B.Braun Coronary Drug Stent System Product Offered
Table 124. B.Braun Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. B.Braun Main Business
Table 126. B.Braun Latest Developments
Table 127. Atrium Medical Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 128. Atrium Medical Coronary Drug Stent System Product Offered
Table 129. Atrium Medical Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Atrium Medical Main Business
Table 131. Atrium Medical Latest Developments
Table 132. SINOMED Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 133. SINOMED Coronary Drug Stent System Product Offered
Table 134. SINOMED Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. SINOMED Main Business
Table 136. SINOMED Latest Developments
Table 137. LBC Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 138. LBC Coronary Drug Stent System Product Offered
Table 139. LBC Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. LBC Main Business
Table 141. LBC Latest Developments
Table 142. Essen Technology Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 143. Essen Technology Coronary Drug Stent System Product Offered
Table 144. Essen Technology Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Essen Technology Main Business
Table 146. Essen Technology Latest Developments
Table 147. Yinyi Biotech CO.,LTD. Basic Information, Coronary Drug Stent System Manufacturing Base, Sales Area and Its Competitors
Table 148. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product Offered
Table 149. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Yinyi Biotech CO.,LTD. Main Business
Table 151. Yinyi Biotech CO.,LTD. Latest Developments
List of Figures
Figure 1. Picture of Coronary Drug Stent System
Figure 2. Coronary Drug Stent System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coronary Drug Stent System Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Coronary Drug Stent System Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Coronary Drug Stent System Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of High Molecular Polymer Carrier
Figure 10. Product Picture of No High Molecular Polymer Carrier
Figure 11. Global Coronary Drug Stent System Sales Market Share by Type in 2021
Figure 12. Global Coronary Drug Stent System Revenue Market Share by Type (2017-2022)
Figure 13. Coronary Drug Stent System Consumed in Hospitals
Figure 14. Global Coronary Drug Stent System Market: Hospitals (2017-2022) & (K Units)
Figure 15. Coronary Drug Stent System Consumed in Clinics
Figure 16. Global Coronary Drug Stent System Market: Clinics (2017-2022) & (K Units)
Figure 17. Global Coronary Drug Stent System Sales Market Share by Application (2017-2022)
Figure 18. Global Coronary Drug Stent System Revenue Market Share by Application in 2021
Figure 19. Coronary Drug Stent System Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Coronary Drug Stent System Revenue Market Share by Company in 2021
Figure 21. Global Coronary Drug Stent System Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Coronary Drug Stent System Revenue Market Share by Geographic Region in 2021
Figure 23. Global Coronary Drug Stent System Sales Market Share by Region (2017-2022)
Figure 24. Global Coronary Drug Stent System Revenue Market Share by Country/Region in 2021
Figure 25. Americas Coronary Drug Stent System Sales 2017-2022 (K Units)
Figure 26. Americas Coronary Drug Stent System Revenue 2017-2022 ($ Millions)
Figure 27. APAC Coronary Drug Stent System Sales 2017-2022 (K Units)
Figure 28. APAC Coronary Drug Stent System Revenue 2017-2022 ($ Millions)
Figure 29. Europe Coronary Drug Stent System Sales 2017-2022 (K Units)
Figure 30. Europe Coronary Drug Stent System Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Coronary Drug Stent System Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Coronary Drug Stent System Revenue 2017-2022 ($ Millions)
Figure 33. Americas Coronary Drug Stent System Sales Market Share by Country in 2021
Figure 34. Americas Coronary Drug Stent System Revenue Market Share by Country in 2021
Figure 35. United States Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Coronary Drug Stent System Sales Market Share by Region in 2021
Figure 40. APAC Coronary Drug Stent System Revenue Market Share by Regions in 2021
Figure 41. China Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Coronary Drug Stent System Sales Market Share by Country in 2021
Figure 48. Europe Coronary Drug Stent System Revenue Market Share by Country in 2021
Figure 49. Germany Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Coronary Drug Stent System Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Coronary Drug Stent System Revenue Market Share by Country in 2021
Figure 56. Egypt Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Coronary Drug Stent System Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Coronary Drug Stent System in 2021
Figure 62. Manufacturing Process Analysis of Coronary Drug Stent System
Figure 63. Industry Chain Structure of Coronary Drug Stent System
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

冠動脈薬剤ステントシステムの世界市場2022-2028：高分子ポリマー担体、高分子ポリマー担体なし

グローバル市場調査会社